It has been found that BITC treatment inhibited the MMP-2/-9 protein expression in a dose-dependent manner, whereas it increased TIMP-2 expression in SK-Hep-1 human hepatoma cells [155]. The gene discussed is MMP2; the disease is hepatocellular carcinoma.